Stock SCPH SCPHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus scPharmaceuticals Inc.

Equities

SCPH

US8106481059

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
3.91 USD -2.49% Intraday chart for scPharmaceuticals Inc. +11.40% -37.64%
May. 14 Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024
May. 14 ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on scPharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

cdc183df68bc7c646fa093.VbwPKsB28bN8FDtFBp_gg1a9fG9unsv1wR6KEwL7hGw.IcQ3e7oUo4UsQlcDf_aKyxLXDAkf1bq2tS3GWDei9wkG7EJ7kDe78kVlYg~4e46a302b1f579f0d133879be5eb3451

Analyst Recommendations on scPharmaceuticals Inc.

Craig-Hallum Starts scPharmaceuticals at Buy With $20 Price Target MT
Jefferies Adjusts scPharmaceuticals Price Target to $16 From $14, Maintains Buy Rating MT
Maxim Adjusts scPharmaceuticals' Price Target to $20 From $13, Keeps Buy Rating MT
SVB Securities Adjusts scPharmaceuticals Price Target to $13 From $12, Maintains Outperform Rating MT
Cowen Starts scPharmaceuticals at Outperform With $25 Price Target MT
SVB Securities Adjusts Price Target on scPharmaceuticals to $12 From $11, Maintains Outperform Rating MT
HC Wainwright Adjusts Price Target on scPharmaceuticals to $18 From $15, Maintains Buy Rating MT
Jefferies Assumes scPharmaceuticals at Buy with $14 Price Target MT
SVB Securities Upgrades scPharmaceuticals to Outperform From Market Perform, Adjusts Price Target to $11 From $6 MT
Maxim Initiates scPharmaceuticals at Buy, Sets $10 Price Target MT
SVB Securities Adjusts scPharmaceuticals' Price Target to $6 from $5, Keeps Market Perform Rating MT
SCPHARMACEUTICALS : SVB Leerink Starts scPharmaceuticals at Market Perform with $6 Price Target MT
SCPHARMACEUTICALS : SVB Leerink Adjusts ScPharmaceuticals' Price Target to $12 from $11, Keeps Market Perform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
3.91 USD
Average target price
19.5 USD
Spread / Average Target
+398.72%
High Price Target
25 USD
Spread / Highest target
+539.39%
Low Price Target
16 USD
Spread / Lowest Target
+309.21%

Consensus detail

Consensus revision (last 18 months)

Analysts covering scPharmaceuticals Inc.

Craig-Hallum
Jefferies & Co.
Maxim
SVB Securities LLC
Cowen
HC Wainwright
SVB Leerink

Ratings for scPharmaceuticals Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SCPH Stock
  4. Consensus scPharmaceuticals Inc.